Prevalence Rate, and Clinical Characteristics of Obesity Hypoventilation Syndrome Via Screening Patients Admitted to Medical Intensive Care Units
1 other identifier
observational
52
1 country
1
Brief Summary
A prospective observation study to screen adult obese (BMI ≥30 kg/m2) patients who were newly admitted to the medical intensive care units and turned out to be diagnosed as Obesity hypoventilation syndrome(OHS). The investigators purpose is to look into the prevalence, predictive factors, and outcomes of OHS in these critically ill patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2014
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 29, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 12, 2016
CompletedFirst Submitted
Initial submission to the registry
September 20, 2016
CompletedFirst Posted
Study publicly available on registry
October 17, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2018
CompletedMarch 12, 2021
October 1, 2016
1.8 years
September 20, 2016
March 10, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Prevalence of obesity hypoventilation syndrome in Asian critically ill patients
Detecting obesity hypoventilation syndrome via screening obesity(BMI\>=30kg/m\^2) in critical care units in Asian.
2-year
Eligibility Criteria
adult obese (BMI ≥30 kg/m2) patients who were newly admitted to the medical intensive care units and turned out to be diagnosed as obesity hypoventilation syndrome
You may qualify if:
- BMI ≥ 30 kg/m2
- Suspected chronic hypercapnia as following Paco2 ≥ 45 mmHg, HCO3- ≥ 27mEq/L or base excess, BE ≥ 2 mEq/L
You may not qualify if:
- Malignancy with lung involvement
- Autoimmune disease with lung involvement
- Moderate to severe obstructive respiratory pattern via spirometry
- Uncontrolled endocrine disease
- Pregnancy
- Pneumonia confirmed by image
- Out-of-hospital cardiac arrest
- Lung edema
- Foreigner of Taiwan
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Taiwan University Hospital
Taipei, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 20, 2016
First Posted
October 17, 2016
Study Start
October 29, 2014
Primary Completion
August 12, 2016
Study Completion
October 31, 2018
Last Updated
March 12, 2021
Record last verified: 2016-10